BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9926000)

  • 1. Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction.
    Takatsuki S; Mitamura H; Sueyoshi K; Kanki H; Furuno I; Ogawa S
    Jpn Heart J; 1998 Sep; 39(5):687-97. PubMed ID: 9926000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
    J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Ogawa S; Mitamura H; Katoh H
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-repolarization refractoriness increases vulnerability to block and initiation of reentrant impulses in heterogeneous infarcted myocardium.
    Cabo C
    Comput Biol Med; 2015 Oct; 65():209-19. PubMed ID: 25987316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
    Zuanetti G; Corr PB
    J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis.
    Cabo C; Boyden PA
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H372-84. PubMed ID: 12388240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
    Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of E4031 and quinidine on atrial and ventricular refractoriness in rabbits in vivo.
    Chan AP; Leung MW; So PP; Guppy LJ; Walker MJ
    Proc West Pharmacol Soc; 2004; 47():39-41. PubMed ID: 15633608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms.
    Miyazaki T; Ogawa S; Sakai T; Hosokawa M; Sakurai K; Nakamura Y
    Jpn Circ J; 1988 Mar; 52(3):254-61. PubMed ID: 3373717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
    Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Kraft P; Kuebler W; Schoels W
    Basic Res Cardiol; 2000 Aug; 95(4):324-32. PubMed ID: 11005588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of d-sotalol on normal and infarcted myocardium: an experimental study using epicardial mapping.
    Freigang KD; Bauer A; Becker R; Senges JC; Kraft P; Brachmann J; Kübler W; Schoels W
    Cardiovasc Res; 1997 Jul; 35(1):52-9. PubMed ID: 9302347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium: a comparison between E4031 and azimilide.
    Shiroshita-Takeshita A; Mitamura H; Sato T; Shinagawa K; Kurita Y; Kanki H; Takatsuki S; Hara M; Ogawa S
    J Cardiovasc Pharmacol; 2003 May; 41(5):678-85. PubMed ID: 12717097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of oxymatrine on arrhythmia in dogs with myocardial infarction].
    Zeng JX; Cao HY; Li Q; Xu Z; Guo ZB
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):379-82. PubMed ID: 9812730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
    Dobmeyer D; Muir WW; Schaal SF
    J Cardiovasc Pharmacol; 1985; 7(2):238-44. PubMed ID: 2581074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative lusitropic effect of DPI 201-106 and E4031. Possible role of prolonging action potential duration.
    Cingolani HE; Wiedmann RT; Lynch JJ; Wenger HC; Scott AL; Siegl PK; Stein RB
    J Mol Cell Cardiol; 1990 Sep; 22(9):1025-34. PubMed ID: 2280413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle.
    Baskin EP; Serik CM; Wallace AA; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):406-14. PubMed ID: 1720841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.